Phone: +86-18519734165
Email: info@assointernationalconsulting.com
Opening:
Get a Quote

About ASSO International Consulting

ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project.

Important Links

  • ASSO
  • 2021-05-16
  • comments

Global Artificial Heart Lung Machines Report

Summary
 
More businesses in the market research, data and insights industry are working toward a step change in their speed, efficiency and product innovation. This has led to a wider demand for more sophisticated and integrated solutions to meet the complex needs of larger established businesses and also newer, hyper-growth and technology-driven companies. ASSO's research report helps decision makers gain insight into market conditions and future trends.
To analyze and research the Artificial Heart Lung Machines sales, revenue, consumption, status and forecast.
To focus on the key Artificial Heart Lung Machines manufacturers and study the sales, value, market share and development plans in next few years.
To define, describe and forecast the market by type, application.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
 
Global Artificial Heart Lung Machines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
 
The major players in global market include
    LivaNova (Sorin)
    Getinge (Maquet)
    Medtronic
    Terumo CV Group
    Braile Biomedica
    Tianjin Medical
    ...
 
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Artificial Heart Lung Machines in these regions, from 2013 to 2024 (forecast), covering
    North America (United States,Canada, Mexico)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Other Regions )
    Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
    South America (Brazil. Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, U.A.E, Other Regions)
 
On the basis of product, the Artificial Heart Lung Machines market is primarily split into
    Single Roller Pump HLM
    Double Roller Pump HLM
 
On the basis on the end users/applications, this report covers
    Cardiac Surgery
    Lung Transplant Operation
    Acute Respiratory Failure Treatment
    Others
 
Table of Contents
1 Target Product and Background
    1.1 Product Overview Artificial Heart Lung Machines
    1.2 Research Method
    1.3 Data Source
    1.4 Project Cycle
    1.5 Forecast Data Base & Factor
    1.6 Macroeconomic Development Trends
    1.7 Impact of COVID-19 on the Economy and Artificial Heart Lung Machines Industry
        1.7.1 Post-COVID-19 era
        1.7.2 The Impact of COVID-19 on Artificial Heart Lung Machines Industry
2 Manufacturers Competitive Analysis of Major Players
    2.1 Competitive Segmentation Analysis of Key Players
    2.2 2016-2021 Key Players Sales Volume and Market Positions
    2.3 Key Players Revenue and Market Positions
3 Artificial Heart Lung Machines Sales Segment Analysis by Type
    3.1 Overview
        3.1.1 Single Roller Pump HLM
        3.1.2 Double Roller Pump HLM
    3.2 2016-2027 Global Artificial Heart Lung Machines Sales Volume Segment Analysis by Type
    3.3 2016-2027 Global Artificial Heart Lung Machines Revenue Segment Analysis by Type
4 Artificial Heart Lung Machines Sales Segment Analysis End User
    4.1 Introduction
        4.1.1 Cardiac Surgery
        4.1.2 Lung Transplant Operation
        4.1.4 Others
    4.2 2016-2027 Global Artificial Heart Lung Machines Sales Volume Segment Analysis by End User
    4.3 2016-2027 Global Artificial Heart Lung Machines Revenue Segment Analysis by End User
5 Artificial Heart Lung Machines Market Analysis, by Region by Country
    5.1 Global Artificial Heart Lung Machines Market Size and Regional Analysis
    5.2 Global Artificial Heart Lung Machines Retrospective Market Scenario in Revenue by Region: 2016-2021
    5.3 North America Market Size and Regional Analysis
        5.3.1 North America Sales by Country
        5.3.2 North America Artificial Heart Lung Machines Revenue by Country
    5.4 Europe Market Size and Regional Analysis
        5.4.1 Europe Artificial Heart Lung Machines Sales by Country
        5.4.2 Europe Artificial Heart Lung Machines Revenue by Country
    5.5 Asia Pacific Market Size and Regional Analysis
        5.5.1 Asia Pacific Artificial Heart Lung Machines Sales by Region
        5.5.2 Asia Pacific Artificial Heart Lung Machines Revenue by Region
    5.6 South America Market Size and Regional Analysis
        5.6.1 South America Artificial Heart Lung Machines Sales by Country
        5.6.2 South America Artificial Heart Lung Machines Revenue by Country
    5.7 Middle East and Africa Market Size and Regional Analysis
        5.7.1 Middle East and Africa Artificial Heart Lung Machines Sales by Country
        5.7.2 Middle East and Africa Artificial Heart Lung Machines Revenue by Country
6 Artificial Heart Lung Machines SWOT and Driving Factor Analysis
    6.1 SWOT Analysis
    6.2 Marketing Strategy
    6.3 Technology Driven Market
    6.4 Artificial Heart Lung Machines Growth Drivers
    6.5 Artificial Heart Lung Machines Market Challenges
    6.6 Artificial Heart Lung Machines Market Restraints
7 Artificial Heart Lung MachinesRaw Material Supply and Industry Chain Analysis
    7.1 Artificial Heart Lung Machines Key Raw Material Supply
        7.1.1 Key Raw Materials
        7.1.2 Key Suppliers of Raw Materials
    7.2 Artificial Heart Lung Machines Industrial Chain Analysis and Reconstruction
8 Global Artificial Heart Lung Machines Major Manufacturers Analysis
    8.1 LivaNova (Sorin)
        8.1.1 LivaNova (Sorin) Corporate Outline
        8.1.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.1.3 LivaNova (Sorin) Artificial Heart Lung Machines  Key Product Overview
        8.1.4 Artificial Heart Lung Machines Key Product Overview
        8.1.5 LivaNova (Sorin) Business Segmentation SWOT Analysis
    8.2 Getinge (Maquet)
        8.2.1 Getinge (Maquet) Corporate Outline
        8.2.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.2.3 Getinge (Maquet) Artificial Heart Lung Machines  Key Product Overview
        8.2.4 Artificial Heart Lung Machines Key Product Overview
        8.2.15Getinge (Maquet) Business Segmentation SWOT Analysis
    8.3 Medtronic
        8.3.1 Medtronic Corporate Outline
        8.3.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.3.3  Artificial Heart Lung Machines  Key Product Overview
        8.3.4 Artificial Heart Lung Machines Key Product Overview
        8.3.5 Medtronic Business Segmentation SWOT Analysis
    8.4 Terumo CV Group
        8.4.1 Terumo CV Group Corporate Outline
        8.4.1 Terumo CV Group Corporate Outline
        8.4.3  Artificial Heart Lung Machines  Key Product Overview
        8.4.4 Artificial Heart Lung Machines Key Product Overview
        8.4.5 Terumo CV Group Business Segmentation SWOT Analysis
    8.5 Braile Biomedica
        8.5.1 Braile Biomedica Corporate Outline
        8.5.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.5.3  Artificial Heart Lung Machines  Key Product Overview
        8.5.4 Artificial Heart Lung Machines Key Product Overview
        8.5.5 Braile Biomedica Business Segmentation SWOT Analysis
    8.6 Tianjin Medical
        8.6.1 Tianjin Medical Corporate Outline
        8.6.2 Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
        8.6.3  Artificial Heart Lung Machines  Key Product Overview
        8.6.4 Artificial Heart Lung Machines Key Product Overview
        8.6.5 Tianjin Medical Business Segmentation SWOT Analysis
9 Artificial Heart Lung Machines Report Conclusion and Strategy
10 Appendix
    10.1 Order and After-sales Service
    10.2 Author List
    10.3 Disclaimer
 
List of Tables and Figures
 
Table 1. Competitive Segmentation Analysis of Key Players
Table 2. 2016-2021 Key Players Sales Volume and Market Positions (K Units)
Table 3. 2016-2021 Key Players Revenue and Market Positions (US$ Million)
Table 4. Global Artificial Heart Lung Machines Market Size Comparison by Type (2021-2027)
Table 5. Analysis of the Distribution of Main Players' Product Types
Table 6. 2016-2027 Global Artificial Heart Lung Machines Sales Volume Segment Analysis by Type (K Units)
Table 7. 2016-2027 Global Artificial Heart Lung Machines Sales Volume Share by Type
Table 8. 2016-2027 Global Artificial Heart Lung Machines Revenue Segment Analysis by Type (US$ Million)
Table 9. Global Artificial Heart Lung Machines Revenue Share by Type (2016-2021)
Table 10. Competitive Segmentation Analysis of Key Players
Table 11. Global Artificial Heart Lung Machines Market Size Comparison by End User (2021-2027)
Table 12. 2016-2027 Global Artificial Heart Lung Machines Sales Volume Segment Analysis by End User (K Units)
Table 13. 2016-2027 Global Artificial Heart Lung Machines Sales Volume Share by End User
Table 14. 2016-2027 Global Artificial Heart Lung Machines Revenue Segment Analysis by End User (US$ Million)
Table 15. Global Artificial Heart Lung Machines Revenue Share by End User (2016-2021)
Table 16. 2016-2027 Global Segment: Artificial Heart Lung Machines Sales Volume Market, by Region (K Units)
Table 17. 2016-2027 Global Segment: Artificial Heart Lung Machines Sales Volume Market Share, by Region
Table 18. 2016-2027 Global Segment: Artificial Heart Lung Machines Revenue Market, by Region (US$ Million)
Table 19. 2016-2027 Global Segment: Artificial Heart Lung Machines Revenue Market Share, by Region
Table 20. 2016-2021E North America Segment: Artificial Heart Lung Machines Sales Volume Market, by Country (K Units)
Table 21. 2016-2021E North America Segment: Artificial Heart Lung Machines Revenue Market, by Country (US$ Million)
Table 22. 2016-2021E Europe Segment: Artificial Heart Lung Machines Sales Volume Market, by Country (K Units)
Table 23. 2016-2021E Europe Segment: Artificial Heart Lung Machines Revenue Market, by Country (US$ Million)
Table 24. 2016-2021E Asia Pacific Segment: Artificial Heart Lung Machines Sales Volume Market, by Country (K Units)
Table 25. 2016-2021E Asia Pacific Segment: Artificial Heart Lung Machines Revenue Market, by Country (US$ Million)
Table 26. 2016-2021E South America Segment: Artificial Heart Lung Machines Sales Volume Market, by Country (K Units)
Table 27. 2016-2021E South America Segment: Artificial Heart Lung Machines Revenue Market, by Country (US$ Million)
Table 28. 2016-2021E Middle East and Africa Segment: Artificial Heart Lung Machines Sales Volume Market, by Country (K Units)
Table 29. Middle East and Africa Artificial Heart Lung Machines Revenue Market Share in 2020, by Country (% Share)
Table 30. 2016-2021E Middle East and Africa Segment: Artificial Heart Lung Machines Revenue Market, by Country (US$ Million)
Table 31. Artificial Heart Lung Machines Growth Drivers
Table 32. Key Suppliers of Raw Materials
Table 33. LivaNova (Sorin) Corporate Outline
Table 34. LivaNova (Sorin) Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 35. LivaNova (Sorin) Key Product Overview
Table 36.  Getinge (Maquet) Corporate Outline
Table 37.  Getinge (Maquet) Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 38. Getinge (Maquet) Key Product Overview
Table 39. Medtronic Corporate Outline
Table 40. Medtronic Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 41. Medtronic Key Product Overview
Table 42. Terumo CV Group Corporate Outline
Table 43. Terumo CV Group Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 44. Terumo CV Group Key Product Overview
Table 45. Braile Biomedica Corporate Outline
Table 46. Braile Biomedica Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 47. Braile Biomedica Key Product Overview
Table 48. Tianjin Medical Corporate Outline
Table 49. Tianjin Medical Breakdown Sales Volume (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2021)
Table 50. Tianjin Medical Key Product Overview
 
List of Figures
Figure 1. Product Picture of Artificial Heart Lung Machines
Figure 2. Proportion of GDP of Major Countries in the World in 2018
Figure 3. Figure Projected Growth Profiles for Major Economies – Regression to the Mean
Figure 4. Figure Key Economies’ Share of World GDP in PPP Terms
Figure 5. Global Economic Forecast in 2050
Figure 6. Global GDP Forecast by Region to 2050
Figure 7. Climate Change Impact on Level of GDP in 2050
Figure 8. Economic Impact of COVID-19 on Major Economies in 2020
Figure 9. IMF's Latest Global Economic Forecast by 2021Q1
Figure 10. Comparative Analysis of the Direct Impact of COVID-19 on the Industry (US$ Million)
Figure 11. Characteristics of the Impact of COVID-19 on the Industry
Figure 12. Key Players Revenue Volume Share in 2020
Figure 13. Global Artificial Heart Lung Machines Revenue Share by Manufacturers in 2020
Figure 14. Market Size Share Comparison by End User
Figure 15. Global Artificial Heart Lung Machines Market Size by Region in 2020
Figure 16. Global Artificial Heart Lung Machines Market Size by Region: 2016 VS 2020 VS 2027
Figure 17. Global Artificial Heart Lung Machines Market Size 2016-2027 (US$ Million)
Figure 18. Global Artificial Heart Lung Machines Market Size 2016-2027 (US$ Million)
Figure 19. 2016-2027 Global Segment: Artificial Heart Lung Machines Sales Volume Market Share, by Region
Figure 20. 2016-2027 Global Segment: Artificial Heart Lung Machines Revenue Market Share, by Region
Figure 21.  North America Artificial Heart Lung Machines Key Player Distribution Analysis
Figure 22. North America Artificial Heart Lung Machines Revenue Market Share in 2020, by Country (% Share)
Figure 23. Europe Artificial Heart Lung Machines Key Player Distribution Analysis
Figure 24. Europe Artificial Heart Lung Machines Revenue Market Share in 2020, by Country (% Share)
Figure 25. Asia Pacific Artificial Heart Lung Machines Key Player Distribution Analysis
Figure 26. Asia Pacific Artificial Heart Lung Machines Revenue Market Share in 2020, by Country (% Share)
Figure 27.  South America Artificial Heart Lung Machines Key Player Distribution Analysis
Figure 28. South America Artificial Heart Lung Machines Revenue Market Share in 2020, by Country (% Share)
Figure 29.  Middle East and Africa Artificial Heart Lung Machines Key Player Distribution Analysis
Figure 30. Artificial Heart Lung Machines Industry SWOT Analysis
Figure 31. Figure Marketing Strategy
Figure 32. Artificial Heart Lung MachinesTechnology Development Trend
Figure 33. Global Stars: The Most Innovative Countries, Ranked by Income Group in 2019
Figure 34. Leading countries by gross research and development (R&D) expenditure worldwide in 2020(in billion U.S. dollars)
Figure 35. Artificial Heart Lung Machines Industrial Chain Analysis
Figure 36. FDI, trade, GDP and GVC trends, 1990–2019
Figure 37. World Carbon Dioxide Emissions from 2009 to 2019, by region (in Million Metric Tons of Carbon Dioxide)
Figure 38. Global Energy Structure Evolution Structure
Figure 39. The Evolution of Global Road Vehicles to 2050
Figure 40. LivaNova (Sorin) SWOT Analysis
Figure 41. Getinge (Maquet) SWOT Analysis
Figure 42. Medtronic SWOT Analysis
Figure 43. Terumo CV Group SWOT Analysis
Figure 44. Braile Biomedica SWOT Analysis
Figure 45. Tianjin Medical SWOT Analysis

ASSO regards each project as the best communication bridge between us and our customers. ASSO solemnly promises that ASSO will treat each project as our most important customer project. We will go all out and never give up. ASSO regards each other's excellence as the purpose of our service. ASSO's services involve regional analysis, market data, player share, market decision-making, marketing and product positioning

– Allen King

Leave a comment

All fields marked with an asterisk (*) are required